Source: European Medicines Agency (EU) Revision Year: 2018 Publisher: Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, The Netherlands
Cholestagel 625 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet (tablet). Off-white, capsule-shaped film-coated tablets imprinted with “C625” on one side. |
Each tablet contains 625 mg colesevelam (as hydrochloride).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Colesevelam |
Colesevelam is a non-absorbed, lipid-lowering polymer that binds bile acids in the intestine, impeding their reabsorption. |
| List of Excipients |
|---|
|
Tablet core: Cellulose (E460), microcrystalline Film-coating: Hypromellose (E464) |
High density polyethylene bottles with a polypropylene cap.
Package sizes are:
24 tablets (1 X 24)
100 tablets (2 X 50)
180 tablets (1 X 180)
High density polyethylene bottles with a polypropylene cap without outer carton.
Package sizes are: 180 tablets (1 X 180)
Not all pack sizes may be marketed.
Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, The Netherlands
EU/1/03/268/001-004
Date of first authorisation: 10 March 2004
Date of latest renewal: 12 March 2009
| Drug | Countries | |
|---|---|---|
| CHOLESTAGEL | Austria, Cyprus, Estonia, Spain, Finland, Croatia, Ireland, Lithuania, Netherlands, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
